Results 301 to 310 of about 163,785 (367)

Metabolomic Panel for the Diagnosis of Heart Failure with Preserved Ejection Fraction. [PDF]

Int J Mol Sci
Kozhevnikova MV, Kakotkina AV, Korobkova EO, Kuznetsov IV, Shestakova KM, Moskaleva NE, Appolonova SA, Belenkov YN.   +7 more
europepmc   +1 more source

Multiorgan characterization of inflammasome component expression in a rat model of advanced heart failure

ESC Heart Failure, EarlyView.
Abstract Aims Targeting inflammasomes in heart failure (HF) might represent a novel therapeutic option. Nevertheless, previous studies focused only on myocardial inflammasome alterations, and data are scarce regarding their regulation and role in HF‐associated multiorgan dysfunction.
Dávid Nagy, Zsófia Onódi, Márton Kocsis, Artúr Tóth, Tímea Bálint, Attila Oláh, Alex Ali Sayour, Bálint András Barta, Béla Merkely, Péter Ferdinandy, Tamás Radovits, Zoltán V. Varga, Mihály Ruppert   +12 more
wiley   +1 more source

Clinical Status and Outcome of Japanese Heart Failure Patients With Reduced or Preserved Ejection Fraction Treated With Carvedilol

, 2013
Yoshihiro Mori, Yasuhiro Nishikawa, Fumiaki Kobayashi, Katsutoshi Hiramatsu   +3 more
openalex   +2 more sources

Patients report increased control and decreased impact of heart failure during pulmonary pressure‐guided management

ESC Heart Failure, EarlyView.
Abstract Aims This study investigated Class III heart failure patient experience with pulmonary artery pressure (PAP) monitoring over 24 months including (1) changes in reported quality of life (QoL), (2) changes in HF illness perception and sense of control (control), (3) patient evaluation of PAP‐guided therapy as a modality and (4) behavioural ...
Lisa D. Rathman, Samuel F. Sears, Marie‐Elena Brett, John D. Henderson, Natalie R. Castillo, Philip B. Adamson, Lynne W. Stevenson   +6 more
wiley   +1 more source

Prognostic value of longitudinal strain relative apical sparing in severe aortic stenosis patients undergoing TAVR

ESC Heart Failure, EarlyView.
Abstract Aims This study evaluated the prognostic value of the relative apical sparing pattern (RASP) of longitudinal strain (LS) in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) and investigated whether its combination with pre‐procedural biomarkers enhances risk stratification.
Dan Liu, Kai Hu, Vera Schimpf, Victoria Sokalski, Friederike Hermann, Björn Daniel Lengenfelder, Georg Ertl, Stefan Frantz, Peter Nordbeck   +8 more
wiley   +1 more source

Prevalence of transthyretin amyloid cardiomyopathy in an unselected cohort with heart failure with preserved ejection fraction. [PDF]

Neth Heart J
Achten A, van Empel VPM, Weerts J, Mourmans S, Brunner-La Rocca HP, Sanders-van Wijk S, Knackstedt C.   +6 more
europepmc   +1 more source

Clinical endpoints in pragmatic heart failure trials: From data collection to clinical endpoint classification

ESC Heart Failure, EarlyView.
Abstract Clinical endpoint classification (CEC)—that is, evaluation of clinical events using pre‐defined criteria—is commonly conducted in clinical trial operations to ensure systematic and consistent assessment of endpoints needed to assess the intervention's safety and efficacy.
Veraprapas Kittipibul, Harriette G.C. Van Spall, William Schuyler Jones, Marat Fudim, Robert J. Mentz, Kevin Anstrom, Bertram Pitt, Patrice Desvigne‐Nickens, Jerome L. Fleg, Camilla Hage, Stefan James, Claes Held, Lars Lund, Adam DeVore   +13 more
wiley   +1 more source

Predictive value of left ventricular myocardial constructive work in patients with heart failure with preserved ejection fraction and preclinical diastolic dysfunction. [PDF]

J Cardiovasc Imaging
Chilingaryan A, Tunyan L, Arzumanyan M, Balyan H.   +3 more
europepmc   +1 more source

Patient‐specific modifiers of survival benefit in cardiac resynchronization therapy ‐ A multicentre interaction analysis

ESC Heart Failure, EarlyView.
Abstract Background Cardiac resynchronization therapy (CRT) is a key intervention for patients with heart failure. The choice between a CRT with defibrillator therapy (CRT‐D) and a CRT with pacemaker (CRT‐P) is influenced by individual clinical characteristics.
Bert Vandenberk, Marius Brusselmans, Gabor Voros, Pieter Martens, Sebastian Ingelaere, Pascal Betschart, Jens‐Uwe Voigt, Matthias Dupont, Alexander Breitenstein, Jan Steffel, Rik Willems, Frank Ruschitzka, Wilfried Mullens, Sander Trenson, Stephan Winnik   +14 more
wiley   +1 more source

Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial. [PDF]

Eur Heart J
Peikert A, Vaduganathan M, Claggett BL, Kulac IJ, Litwin S, Zile M, Desai AS, Jhund PS, Butt JH, Lam CSP, Martinez F, Van Veldhuisen DJ, Zannad F, Rouleau J, Lefkowitz M, McMurray JJV, Solomon SD, Packer M.   +17 more
europepmc   +1 more source